# Study of CM518D1 in Patients With Advanced Solid Tumors

Source: https://onco.cc/trials/nct07019779/  
OnCo record `nct07019779` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of CM518D1 in advanced solid tumours, run by Keymed Biosciences Co.Ltd, now recruiting.

## Summary

Study of CM518D1 in Patients With Advanced Solid Tumors is a phase 1/2 interventional study registered as NCT07019779 by Keymed Biosciences Co.Ltd, with 434 participants planned, started 2025-06-27 and due to reach its primary completion in 2028-12-31. Interventions recorded: CM518D1.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT07019779
- Phase: 1/2
- Setting: A Multicenter, Open-Label, Phase I/II Clinical Study to Evaluate CM518D1 in the Treatment of Patients With Advanced Solid Tumors
- Sponsor: Keymed Biosciences Co.Ltd
- Enrolled: 434

## Sources

- ClinicalTrials.gov NCT07019779: https://clinicaltrials.gov/study/NCT07019779

## Connected records

- cancers: [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/)
- companies: [Keymed Biosciences (KYM Biosciences)](https://onco.cc/companies/keymed/)

---
JSON: https://onco.cc/api/v1/entities/nct07019779.json